Skip to main navigation Skip to search Skip to main content

Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor

Research output: Contribution to journalArticlepeer-review

Abstract

A methylenebis(sulfonamide) linked NAD analogue has been designed to circumvent the metabolically unstable, ionic nature of the natural pyrophosphate linkage. This NAD analogue is assembled through two Mitsunobu reactions of a methylenebis(sulfonamide) linker with two protected nucleosides. A 2,4-dimethoxybenzyl group is used as a sulfonamide protective group, which allows facile removal under mildly acidic conditions. This NAD analogue inhibits IMPDH at low micromolar concentration.

Original languageEnglish (US)
Pages (from-to)3152-3155
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume17
Issue number11
DOIs
StatePublished - Jun 1 2007

Bibliographical note

Funding Information:
These studies were funded by the Center for Drug Design, University of Minnesota, and USDOD ARMY Grant W81XWH-05-01-0216.

Keywords

  • IMPDH
  • Inosine monophosphate dehydrogenase
  • Methylenebis(sulfonamide)
  • NAD analogue
  • Pyrophosphate mimics

Fingerprint

Dive into the research topics of 'Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor'. Together they form a unique fingerprint.

Cite this